Israël - anglais - Ministry of Health

alexion pharma israel ltd - sebelipase alfa - concentrate for solution for infusion - sebelipase alfa 2 mg / 1 ml - sebelipase alfa - kanuma is indicated for long-term enzyme replacement therapy (ert) in patients of all ages with lysosomal acid lipase (lal) deficiency.

Pérou - espagnol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inretail pharma s.a. - droguerÍa - diclofenaco dietilamina; - gel - por gramo g - - diclofenaco

Israël - hébreu - Ministry of Health

alexion pharma israel ltd - eculizumab - תרכיז להכנת תמיסה לאינפוזיה - eculizumab 10 mg/ml - eculizumab - eculizumab - soliris is indicated for the treatment of patients with: - paroxysmal nocturnal hemoglobinuria ( pnh ).- atypical hemolytic uremic syndrome (ahus).

Australie - anglais - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - macrogol 3350, quantity: 1 g/g - solution, powder for - excipient ingredients: - decrease/reduce/relieve constipation ; aperient/laxative ; helps reduce occurrence of constipation

Australie - anglais - Department of Health (Therapeutic Goods Administration)

lacorium health international pty ltd - arnica montana,lactic acid,salicylic acid -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

lacorium health international pty ltd - undecenoic acid, quantity: 250 mg/g - liquid, multipurpose - excipient ingredients: eucalyptus oil; urea; hypromellose; aloe vera; isopropyl alcohol; melaleuca oil; purified water; dl-alpha-tocopheryl acetate; butylated hydroxytoluene

Australie - anglais - Department of Health (Therapeutic Goods Administration)

lacorium health international pty ltd - wintergreen oil, quantity: 100 mg/g (equivalent: methyl salicylate, qty 100 mg/g) - gel - excipient ingredients: peg-40 hydrogenated castor oil; ethanol; arnica montana; peppermint oil; benzyl alcohol; purified water; polyacrylamide; c13-14 isoparaffin; laureth-7; mixed (low-alpha type) tocopherols concentrate; soya oil

Union européenne - maltais - EMA (European Medicines Agency)

alexion europe sas - ravulizumab - emoglobinurja, paroxysmal - immunosuppressanti selettivi - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.

Taïwan - chinois - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

井田國際醫藥廠股份有限公司 台中市大甲區幼獅路32號 (24430803) - aluminum hydroxide hexitol;;homatropine methylbromide - 錠劑 - homatropine methylbromide (5224000220) mg; aluminum hydroxide hexitol (5604003200) mg - antacids with antispasmodics - 緩解胃部不適或灼熱感、胃酸過多、消化不良

Union européenne - français - EMA (European Medicines Agency)

alexion europe sas - sebelipase alfa - métabolisme lipidique, erreurs innées - d'autres tractus digestif et le métabolisme des produits, - kanuma est indiqué pour une thérapie de substitution enzymatique (ert) à long terme chez des patients de tout âge présentant un déficit en lipase acide lysosomale (lal)..